Aralez Pharmaceuticals Inc. 4
4 · Aralez Pharmaceuticals Inc. · Filed Jun 24, 2016
Insider Transaction Report
Form 4
Glickman Mark A
Chief Commercial Officer
Transactions
- Tax Payment
Common Shares, without par value
2016-06-22$3.34/sh−10,803$36,082→ 175,750 total
Footnotes (1)
- [F1]This represents shares withheld by the Issuer for payment of withholding tax liability incurred upon the vesting of 28,999 restricted stock units, 7,284 of which were previously granted on June 22, 2015 and 21,715 of which were previously granted on February 12, 2016, all of which vested on June 22, 2016.